This project aims to improve the production of monoclonal antibody (mAb) based medicines by developing a novel method for measuring antifoaming agents within perfusion bioreactors used to produce mAbs. Antifoams are necessary to keep bioreactors running smoothly, but they are also widely believed to contribute to reactor membrane fouling, which increases costs and severely limits […]
Read More